新型降糖药物对2型糖尿病患者心脑血管事件影响的研究进展  

Progress of Effects of New Hypoglycemic Drugs on Cardio-and Cerebrovascular Events in Patients with Type 2 Diabetes Mellitus

作　　者：蔺建蕊 崔向丽 米东华[2] 李子孝[2] 赵性泉[2] 王拥军[2] LIN Jian-Rui;CUI Xiang-Li;MI Dong-Hua;LI Zi-Xiao;ZHAO Xing-Quan;WANG Yong-Jun(Department of Pharmacy,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China)

机构地区：[1]首都医科大学附属北京友谊医院西药剂科,北京100050 [2]首都医科大学附属北京天坛医院神经病学中心血管神经病学科

出　　处：《中国卒中杂志》2021年第7期739-745,共7页Chinese Journal of Stroke

基　　金：国家自然科学基金(81971092)。

摘　　要：2型糖尿病(type 2 diabetes mellitus,T2DM)是心脑血管疾病的独立危险因素,同时心血管疾病也是导致T2DM患者死亡的主要原因之一。近年来针对新型降糖药物的临床研究显示,胰高血糖素样肽-1受体激动剂可能对预防T2DM患者心脑血管事件有益;钠-葡萄糖共转运蛋白2抑制剂可降低糖尿病患者心血管事件和心力衰竭的风险,但降低脑血管事件风险的临床证据并不足;目前尚无二肽激肽酶-4抑制剂对T2DM患者心脑血管事件影响的可靠证据。因此,需要更多的临床研究来提供新型降糖药物对心脑血管事件,尤其是对脑血管事件发生和预后影响的临床证据。Type 2 diabetes mellitus(T2 DM)is an independent risk factor for cardio-and cerebrovascular diseases.Cardiovascular disease is also one of the main causes of death in T2 DM patients.So it is important for T2 DM patients to find new hypoglycemic drugs which also have cardio-and cerebrovascular protective effect.The recent studies about new hypoglycemic agents showed that glucagon-like peptide 1 receptor agonists(GLP-1 RA)may be beneficial for preventing cardio-and cerebrovascular events in T2 DM patients.The clinical evidences showed that sodiumglucose cotransporter 2 inhibitor(SGLT2 I)can reduce the risk of cardiovascular events and heart failure in T2 DM patients,but the benefit evidence in cerebrovascular events is insufficient.There is no clear evidence that dipeptidyl peptidase 4 inhibitor(DPP-4 I)can reduce the risk of cardioand cerebrovascular events.More researches were needed to provide the evidence of the effects of new hypoglycemic agents on cardio-and cerebrovascular events,especially for the occurrence and functional prognosis of stroke.

关 键 词：心脑血管事件 新型降糖药 胰高血糖素样肽-1受体激动剂 二肽激肽酶-4抑制剂 钠-葡萄糖共转运蛋白2抑制剂 

分 类 号：R587.2[医药卫生—内分泌]